Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help ...

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

Although the ad does not identify the medication, Hims & Hers offers compounded versions of the weight-loss drug semaglutide, which was developed by Novo Nordisk and is typically sold under the ...

A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.

Hims & Hers is under scrutiny for promoting compounded weight-loss ... semaglutide as “in shortage,” while another says that all doses are available. The shortage of tirzepatide, the drug ...

At the least, the new 7.2mg results point to scope for hiking the semaglutide dose in CagriSema to chase down that weight-loss target. The company is also running a phase 3b trial of 7.2mg ...

The past few days haven't been kind to most stocks in the white-hot obesity drugs space. One developer of a weight loss ...

That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super Bowl ad, leveling the accusation against brand-name weight loss drugs ... that patients get the correct dose. Compounded ...

Higher-dose weight loss injections now available." A new study increases max-dose guidance for semaglutide. This offers hope for those who didn’t reach their weight goals. The Injection and ...

A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.